Terms: = Liver cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Staging
20 results:
1. SOX2 and bcl-2 as a Novel Prognostic Value in Hepatocellular Carcinoma Progression.
Hosseini-Khah Z; Babaei MR; Tehrani M; Cucchiarini M; Madry H; Ajami A; Rakhshani N; Rafiei A; Nikbin B
Curr Oncol; 2021 Aug; 28(4):3015-3029. PubMed ID: 34436030
[TBL] [Abstract] [Full Text] [Related]
2. [Prognostic factor analysis of patients with unresectablelung squamous cell carcinoma].
Gao X; Li Z; Shao XY; Liu XM; Liu C; Liu YP; Qu XJ; Zhang LY
Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):569-573. PubMed ID: 34034477
[No Abstract] [Full Text] [Related]
3. A proposed modification for the Barcelona Clinic liver cancer staging system: Adding bile duct tumor thrombus status in patients with hepatocellular carcinoma.
Lu WP; Tang HW; Yang ZY; Jiang K; Chen YL; Lu SC
Am J Surg; 2020 Oct; 220(4):965-971. PubMed ID: 32336518
[TBL] [Abstract] [Full Text] [Related]
4. Embolotherapy of unresectable hepatocellular carcinoma: Eastern perspective.
Lu J; Zhong BY; Zhu HD; Guo JH; Teng GJ
Chin Clin Oncol; 2019 Dec; 8(6):60. PubMed ID: 31865712
[TBL] [Abstract] [Full Text] [Related]
5. PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations.
Mayerhoefer ME; Prosch H; Beer L; Tamandl D; Beyer T; Hoeller C; Berzaczy D; Raderer M; Preusser M; Hochmair M; Kiesewetter B; Scheuba C; Ba-Ssalamah A; Karanikas G; Kesselbacher J; Prager G; Dieckmann K; Polterauer S; Weber M; Rausch I; Brauner B; Eidherr H; Wadsak W; Haug AR
Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):51-60. PubMed ID: 31410538
[TBL] [Abstract] [Full Text] [Related]
6. Identification and validation of a potent multi-mRNA signature for the prediction of early relapse in hepatocellular carcinoma.
Cai J; Tong Y; Huang L; Xia L; Guo H; Wu H; Kong X; Xia Q
Carcinogenesis; 2019 Jul; 40(7):840-852. PubMed ID: 31059567
[TBL] [Abstract] [Full Text] [Related]
7. Effects of cyclin D1 gene silencing on cell proliferation, cell cycle, and apoptosis of hepatocellular carcinoma cells.
Chen J; Li X; Cheng Q; Ning D; Ma J; Zhang ZP; Chen XP; Jiang L
J Cell Biochem; 2018 Feb; 119(2):2368-2380. PubMed ID: 28885717
[TBL] [Abstract] [Full Text] [Related]
8. FSTL1 contributes to tumor progression via attenuating apoptosis in a AKT/GSK-3β - dependent manner in hepatocellular carcinoma.
Yang W; Wu Y; Wang C; Liu Z; Xu M; Zheng X
Cancer Biomark; 2017 Jul; 20(1):75-85. PubMed ID: 28655132
[TBL] [Abstract] [Full Text] [Related]
9. RIP1 upregulation promoted tumor progression by activating AKT/bcl-2/BAX signaling and predicted poor postsurgical prognosis in HCC.
Wang C; Yao B; Xu M; Zheng X
Tumour Biol; 2016 Nov; 37(11):15305-15313. PubMed ID: 27699664
[TBL] [Abstract] [Full Text] [Related]
10. Solitary fibrous tumour of the supraglottic larynx.
Grammatica A; Bolzoni Villaret A; Ravanelli M; Nicolai P
Acta Otorhinolaryngol Ital; 2016 Jun; 36(3):239-43. PubMed ID: 27070539
[TBL] [Abstract] [Full Text] [Related]
11. [A Case of a Metastatic liver Tumor from a Thymic Carcinoma Detected During a Cesarean Section].
Morinaka T; Takeuchi D; Noro A; Saotome T; Yoshimura K; Kaneko T; Miura S; Kamiya J; Ashizawa Y; Akikusa B; Ogata A
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1824-6. PubMed ID: 26805185
[TBL] [Abstract] [Full Text] [Related]
12. Rab31 promoted hepatocellular carcinoma (HCC) progression via inhibition of cell apoptosis induced by PI3K/AKT/bcl-2/BAX pathway.
Sui Y; Zheng X; Zhao D
Tumour Biol; 2015 Nov; 36(11):8661-70. PubMed ID: 26044564
[TBL] [Abstract] [Full Text] [Related]
13. Bag-3 expression is involved in pathogenesis and progression of colorectal carcinomas.
Yang X; Tian Z; Gou WF; Takahashi H; Yu M; Xing YN; Takano Y; Zheng HC
Histol Histopathol; 2013 Sep; 28(9):1147-56. PubMed ID: 23553442
[TBL] [Abstract] [Full Text] [Related]
14. Relationship between the expression of the extracellular matrix genes SPARC, SPP1, FN1, ITGA5 and ITGAV and clinicopathological parameters of tumor progression and colorectal cancer dissemination.
Viana Lde S; Affonso RJ; Silva SR; Denadai MV; Matos D; Salinas de Souza C; Waisberg J
Oncology; 2013; 84(2):81-91. PubMed ID: 23128103
[TBL] [Abstract] [Full Text] [Related]
15. [Malignant solitary fibrous tumour of the kidney: report of a case and cumulative analysis of the literature].
de Martino M; Böhm M; Klatte T
Aktuelle Urol; 2012 Jan; 43(1):59-62. PubMed ID: 22271338
[TBL] [Abstract] [Full Text] [Related]
16. [Rectal non-Hodgkin lymphoma with concomitant rectal adenocarcinoma: a case report and literature review].
Song W; He YL; Han FH; Cai SR; Peng JJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):617-9. PubMed ID: 21866456
[TBL] [Abstract] [Full Text] [Related]
17. 18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases.
Riedl CC; Akhurst T; Larson S; Stanziale SF; Tuorto S; Bhargava A; Hricak H; Klimstra D; Fong Y
J Nucl Med; 2007 May; 48(5):771-5. PubMed ID: 17475966
[TBL] [Abstract] [Full Text] [Related]
18. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?
Farinati F; Marino D; De Giorgio M; Baldan A; Cantarini M; Cursaro C; Rapaccini G; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M; Trevisani F
Am J Gastroenterol; 2006 Mar; 101(3):524-32. PubMed ID: 16542289
[TBL] [Abstract] [Full Text] [Related]
19. Immunohistochemical detection of bcl-2 protein in small cell carcinomas.
Yan JJ; Chen FF; Tsai YC; Jin YT
Oncology; 1996; 53(1):6-11. PubMed ID: 8570134
[TBL] [Abstract] [Full Text] [Related]
20. The pattern of spread and survival in 596 cases of breast cancer related to clinical staging and histological grade.
Bunting JS; Hemsted EH; Kremer JK
Clin Radiol; 1976 Jan; 27(1):9-15. PubMed ID: 177243
[TBL] [Abstract] [Full Text] [Related]
